-
1
-
-
33644819162
-
-
Éditions de l'Inserm, Paris, Expertise collective de l'Inserm
-
Expertise collective de l'Inserm Déficiences et handicaps d'origine périnatale 2004, Éditions de l'Inserm, Paris.
-
(2004)
Déficiences et handicaps d'origine périnatale
-
-
-
2
-
-
40049098369
-
Neurodevelopmental disabilities and special care of 5-year-old children born before 33weeks of gestation (the EPIPAGE study): a cohort longitudinal study
-
Larroque B., Ancel P.Y., Marret S., et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33weeks of gestation (the EPIPAGE study): a cohort longitudinal study. Lancet 2008, 371:813-820.
-
(2008)
Lancet
, vol.371
, pp. 813-820
-
-
Larroque, B.1
Ancel, P.Y.2
Marret, S.3
-
3
-
-
72049121445
-
Outcomes at age 2years of infants<28weeks'gestational age born in Victoria in 2005
-
Doyle L.W., Roberts G., Anderson P.J., et al. Outcomes at age 2years of infants<28weeks'gestational age born in Victoria in 2005. J Pediatr 2010, 156:49-53.
-
(2010)
J Pediatr
, vol.156
, pp. 49-53
-
-
Doyle, L.W.1
Roberts, G.2
Anderson, P.J.3
-
4
-
-
38149116341
-
An overview of mortality and sequelae of pre-term birth from infancy to adulthood
-
Saigal S., Doyle L.W. An overview of mortality and sequelae of pre-term birth from infancy to adulthood. Lancet 2008, 371:261-269.
-
(2008)
Lancet
, vol.371
, pp. 261-269
-
-
Saigal, S.1
Doyle, L.W.2
-
5
-
-
74049090333
-
Prises en charge éducatives spécifiques de l'enfant grand prématuré à 5 et 8ans: résultats de l'étude EPIPAGE
-
Marret S., Ancel P-Y., Marchand L., et al. Prises en charge éducatives spécifiques de l'enfant grand prématuré à 5 et 8ans: résultats de l'étude EPIPAGE. Arch Pediatr 2009, 16:S17-S27.
-
(2009)
Arch Pediatr
, vol.16
-
-
Marret, S.1
Ancel, P.-Y.2
Marchand, L.3
-
6
-
-
36849058183
-
Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and five-year neurodevelopmental outcomes of very pre-term infants: the EPIPAGE Cohort study
-
Foix-l'Hélias L., Marret S., Ancel P-Y., et al. Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and five-year neurodevelopmental outcomes of very pre-term infants: the EPIPAGE Cohort study. BJOG 2008, 115:275-282.
-
(2008)
BJOG
, vol.115
, pp. 275-282
-
-
Foix-l'Hélias, L.1
Marret, S.2
Ancel, P.-Y.3
-
7
-
-
74049123563
-
Effects of Prenatal Low-Dose Aspirin on Neurodevelopmental and Behavioral Outcomes of Children Born Very-pre-term: results from the EPIPAGE Study
-
Marret S., Marchand L., Kaminski M., et al. Effects of Prenatal Low-Dose Aspirin on Neurodevelopmental and Behavioral Outcomes of Children Born Very-pre-term: results from the EPIPAGE Study. Pediatrics 2010, 125:e29-e34.
-
(2010)
Pediatrics
, vol.125
-
-
Marret, S.1
Marchand, L.2
Kaminski, M.3
-
8
-
-
0036135872
-
Melatoninergic neuroprotection of the murine white matter against excitotoxic challenge
-
Husson I., Mesplès B., Bac P., et al. Melatoninergic neuroprotection of the murine white matter against excitotoxic challenge. Ann Neurol 2002, 51:82-92.
-
(2002)
Ann Neurol
, vol.51
, pp. 82-92
-
-
Husson, I.1
Mesplès, B.2
Bac, P.3
-
9
-
-
69549108304
-
Magnesium sulfate for pre-term labor and pre-term birth
-
for the Society for Maternal-fetal Medicine
-
Mercer B.M., Merlino A.A. Magnesium sulfate for pre-term labor and pre-term birth. Obstet Gynecol 2009, 114:650-668. for the Society for Maternal-fetal Medicine.
-
(2009)
Obstet Gynecol
, vol.114
, pp. 650-668
-
-
Mercer, B.M.1
Merlino, A.A.2
-
10
-
-
34249896158
-
Antenatal magnesium sulphate neuroprotection in the pre-term infant
-
Marret S., Doyle L.W., Crowther C.A., et al. Antenatal magnesium sulphate neuroprotection in the pre-term infant. Semin Fetal Neonat Med 2007, 12:311-317.
-
(2007)
Semin Fetal Neonat Med
, vol.12
, pp. 311-317
-
-
Marret, S.1
Doyle, L.W.2
Crowther, C.A.3
-
11
-
-
0029064353
-
Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies
-
Marret S., Gressens P., Gadisseux J.F., et al. Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies. Dev Med Child Neurol 1995, 37:473-484.
-
(1995)
Dev Med Child Neurol
, vol.37
, pp. 473-484
-
-
Marret, S.1
Gressens, P.2
Gadisseux, J.F.3
-
12
-
-
0026542272
-
Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies
-
Kuban K., Leviton A., Pagano M., et al. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol 1992, 7:70-76.
-
(1992)
J Child Neurol
, vol.7
, pp. 70-76
-
-
Kuban, K.1
Leviton, A.2
Pagano, M.3
-
13
-
-
0028939566
-
Can magnesium sulphate reduce the risk of cerebral palsy in very low birth weight infants?
-
Nelson K.B., Grether J.K. Can magnesium sulphate reduce the risk of cerebral palsy in very low birth weight infants?. Pediatrics 1995, 95:263-269.
-
(1995)
Pediatrics
, vol.95
, pp. 263-269
-
-
Nelson, K.B.1
Grether, J.K.2
-
15
-
-
0029902517
-
Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very lbw children aged 3 to 5years
-
Schendel D.E., Berg C.J., Yeargin-Allsopp M., et al. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very lbw children aged 3 to 5years. JAMA 1996, 276:1805-1810.
-
(1996)
JAMA
, vol.276
, pp. 1805-1810
-
-
Schendel, D.E.1
Berg, C.J.2
Yeargin-Allsopp, M.3
-
16
-
-
0034937843
-
Effect of maternal tocolysis on the incidence of severe periventricular/IVH in very low birth weight infants
-
Weintraub Z., Solovechick M., Reichman B., et al. Effect of maternal tocolysis on the incidence of severe periventricular/IVH in very low birth weight infants. Arch Dis Child Fetal and Neonat Ed 2001, 85:F13-F17.
-
(2001)
Arch Dis Child Fetal and Neonat Ed
, vol.85
-
-
Weintraub, Z.1
Solovechick, M.2
Reichman, B.3
-
17
-
-
0033825505
-
Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia
-
Grether J.K., Hoogstrate J., Walsh-Greene E., et al. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstet Gynecol 2000, 183:717-725.
-
(2000)
Am J Obstet Gynecol
, vol.183
, pp. 717-725
-
-
Grether, J.K.1
Hoogstrate, J.2
Walsh-Greene, E.3
-
18
-
-
0036085123
-
Association between the use of magnesium sulfate in pre-term labor and adverse health outcomes in infants
-
Mittendorf R., Dambrosia J., Pryde P.G., et al. Association between the use of magnesium sulfate in pre-term labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002, 186:1111-1118.
-
(2002)
Am J Obstet Gynecol
, vol.186
, pp. 1111-1118
-
-
Mittendorf, R.1
Dambrosia, J.2
Pryde, P.G.3
-
19
-
-
0345374593
-
Effect of magnesium sulphate given for neuroprotection before pre-term birth: a randomised-controlled trial
-
Crowther C.A., Hiller J.E., Doyle L.W., et al. Effect of magnesium sulphate given for neuroprotection before pre-term birth: a randomised-controlled trial. JAMA 2003, 290:2669-2676.
-
(2003)
JAMA
, vol.290
, pp. 2669-2676
-
-
Crowther, C.A.1
Hiller, J.E.2
Doyle, L.W.3
-
20
-
-
33847007984
-
Magnesium sulphate given before very pre-term birth to protect infant brain: the randomised-controlled PREMAG trial
-
Marret S., Marpeau L., Zupan-Simunek V., et al. Magnesium sulphate given before very pre-term birth to protect infant brain: the randomised-controlled PREMAG trial. BJOG 2007, 114:310-318.
-
(2007)
BJOG
, vol.114
, pp. 310-318
-
-
Marret, S.1
Marpeau, L.2
Zupan-Simunek, V.3
-
21
-
-
38049091949
-
Benefit of magnesium sulfate given before very pre-term birth to protect infant brain
-
Marret S., Marpeau L., Bénichou J. Benefit of magnesium sulfate given before very pre-term birth to protect infant brain. Pediatrics 2008, 121:225-226.
-
(2008)
Pediatrics
, vol.121
, pp. 225-226
-
-
Marret, S.1
Marpeau, L.2
Bénichou, J.3
-
22
-
-
40949144801
-
Effet du sulfate de magnésium sur la mortalité et la morbidité neurologique chez le prématuré de moins de trente-trois semaines, avec recul à deux ans: résultats de l'essai prospectif multicentrique contre placebo PREMAG
-
Marret S., Marpeau L., Follet-Bouhamed C., et al. Effet du sulfate de magnésium sur la mortalité et la morbidité neurologique chez le prématuré de moins de trente-trois semaines, avec recul à deux ans: résultats de l'essai prospectif multicentrique contre placebo PREMAG. Gynecol Obstet Fertil 2008, 36:278-288.
-
(2008)
Gynecol Obstet Fertil
, vol.36
, pp. 278-288
-
-
Marret, S.1
Marpeau, L.2
Follet-Bouhamed, C.3
-
23
-
-
50449093260
-
A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy
-
Rouse D.J., Hirtz D.G., Thom E., et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008, 359:895-905.
-
(2008)
N Engl J Med
, vol.359
, pp. 895-905
-
-
Rouse, D.J.1
Hirtz, D.G.2
Thom, E.3
-
24
-
-
0036606736
-
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial
-
The Magpie Trial Collaborative Group
-
The Magpie Trial Collaborative Group Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002, 359:1877-1890.
-
(2002)
Lancet
, vol.359
, pp. 1877-1890
-
-
-
25
-
-
0032145390
-
If tocolytic magnesium sulphate is associated with excess total pediatric mortality, what is its impact?
-
Mittendorf R., Pryde P., Khoshnood B., et al. If tocolytic magnesium sulphate is associated with excess total pediatric mortality, what is its impact?. Obstet Gynecol 1998, 92:308-311.
-
(1998)
Obstet Gynecol
, vol.92
, pp. 308-311
-
-
Mittendorf, R.1
Pryde, P.2
Khoshnood, B.3
-
26
-
-
17144458130
-
Tocolytic magnesium sulphate and paediatric mortality
-
Benichou J., Zupan V., Fernandez H., et al. Tocolytic magnesium sulphate and paediatric mortality. Lancet 1998, 351:290-291.
-
(1998)
Lancet
, vol.351
, pp. 290-291
-
-
Benichou, J.1
Zupan, V.2
Fernandez, H.3
-
28
-
-
66649083892
-
Antenatal magnesium sulphate and neurologic outcome in pre-term infants
-
Doyle L.W., Crowther C.A., Middleton P., et al. Antenatal magnesium sulphate and neurologic outcome in pre-term infants. Obstet Gynecol 2009, 113:1327-1333.
-
(2009)
Obstet Gynecol
, vol.113
, pp. 1327-1333
-
-
Doyle, L.W.1
Crowther, C.A.2
Middleton, P.3
-
29
-
-
66149146655
-
Antenatal magnesium sulfate for the prevention of cerebral palsy in pre-term infants less than 34weeks'gestation: a systematic review and meta-analysis
-
Conde-Agudelo A., Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in pre-term infants less than 34weeks'gestation: a systematic review and meta-analysis. Am J Obstet Gynecol 2009, 200:595-609.
-
(2009)
Am J Obstet Gynecol
, vol.200
, pp. 595-609
-
-
Conde-Agudelo, A.1
Romero, R.2
-
30
-
-
68949111738
-
Effects of Antenatal Exposure to Magnesium Sulfate on Neuroprotection and Mortality in Preterm Infants. A Meta-analysis
-
for the Eunice Kennedy Shriver National Institute of Child health and Human Development Maternal-Fetal Medicine Units Network
-
Costantine M.M., Weiner S.J. Effects of Antenatal Exposure to Magnesium Sulfate on Neuroprotection and Mortality in Preterm Infants. A Meta-analysis. Obstet Gynecol 2009, 114:354-364. for the Eunice Kennedy Shriver National Institute of Child health and Human Development Maternal-Fetal Medicine Units Network.
-
(2009)
Obstet Gynecol
, vol.114
, pp. 354-364
-
-
Costantine, M.M.1
Weiner, S.J.2
|